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Evaluating the impact of genetic variants on transcriptional regulation is a central goal in 
biological science that has been constrained by reliance on a single reference genome. To 
address this, we constructed phased, diploid genomes for four cadaveric donors (using long-
read sequencing) and systematically charted noncoding regulatory elements and transcriptional 
activity across more than 25 tissues from these donors. Integrative analysis revealed over a 
million variants with allele-specific activity, coordinated, locus-scale allelic imbalances, and 
structural variants impacting proximal chromatin structure. We relate the personal genome 
analysis to the ENCODE encyclopedia, annotating allele- and tissue-specific elements that are 
strongly enriched for variants impacting expression and disease phenotypes. These 
experimental and statistical approaches, and the corresponding EN-TEx resource, provide a 




.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 




The Human Genome Project assembled one representative haploid genome sequence 20 years 
ago (1). Since then, millions of individual genomes have been sequenced (2). Compared to the 
reference, a personal genome typically contains ~4.5 million variants (3). Understanding their 
functional impact is a fundamental question in biology and medicine. To this end, researchers 
have conducted many genome-wide association studies (GWASes) and expression quantitative 
trait loci (eQTL) analyses, associating genetic variants with changes in gene expression and 
phenotypic traits. In part(4)icular, the Genotype-Tissue Expression (GTEx) project performed 
RNA-seq on >40 human tissues from nearly 1000 individuals, allowing for the identification of 
>175K eQTLs (5, 6). In complementary fashion, the Encyclopedia of DNA Elements (ENCODE) 
project was initiated in 2003 to identify and annotate genomic regions (7). During the ensuing 
decades, the project utilized functional genomic techniques to chart the transcriptional and 
epigenomic landscapes of numerous human tissues and cell lines, producing a catalog of 
candidate cis-regulatory elements (cCREs) on the reference genome (8-10). These are widely 
used for predicting the impact of genetic variants (10-13). However, there is a lack of one-to-one 
correspondence between this epigenetic annotation, based on the generic reference genome, 
and genetic variants, which fundamentally relate to an individual's personal genome.  
 
To overcome this limitation, we initiated the EN-TEx study (ENCODE assays applied to GTEx 
samples) to connect personal genomes and functional genomics. First, we built the diploid 
genomes for each of four individuals with long-read sequencing. Second, for each individual, we 
uniformly carried out a full range of functional genomic assays for 25 tissues, resulting in >1,500 
datasets for histone modifications, gene expression, protein abundance, and three-dimensional 
genome structure. These raw data were processed in relation to each individual's personal 
genome, making the interpretation of genetic variants more direct.  
In particular, by using an individual’s diploid genome, heterozygous loci can distinguish reads 
that arise from each haplotype, assigning distinct molecular signals (e.g., RNA expression or TF 
binding) to each. The imbalance between the haplotypes can be accurately measured by taking 
the wild-type allele as a baseline, avoiding biological and technical biases, and if the imbalance 
is statistically significant, the heterozygous variant is termed allele-specific (AS). AS variants 
have been determined in numerous previous studies(14-20). (Note that only some AS variants 
are causal for the observed changes, such as those directly affecting TF-binding sites on one 
haplotype.) 
Personal genomes & matched data matrix 
Phasing & SVs. We sequenced the genomes of four individuals from the GTEx cohort (identified 
as 1 through 4), with a variety of sequencing technologies (10x Genomics linked-read, Illumina, 
and PacBio). After calling single-nucleotide variants (SNVs) and small insertions and deletions, 
we integrated the haplotype information from linked-reads and proximal ligation sequencing (Hi-
C) to phase the variants (Fig. S1.1) (21). This step generated large blocks of phased variants 
across the genome, which were stitched together, forming phased personal genomes for the 
four individuals (Fig. 1A). We further determined the paternal/maternal origin of the phased 
segments by checking the AS expression levels of known imprinted loci (Fig. 1A and 
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Supplement). For individuals 2 and 3, we also identified 17,649 and 18,542 structural variants 
(SVs, greater than 50 bp; Supplement, Fig. 1B & S1.2), incorporating them into their personal 
genomes. We found that the SVs tended to be short (<1 Kb) and depleted in most functional 
regions (e.g., exons and cCREs), to be insertions, and to have typical allele-frequency spectra, 
all of which agree with previous findings (Fig. S1.2) (22, 23).  
Diploid Mappings from >1500 Experiments. Next, we carried out a comprehensive set of 1635 
experiments on the four individuals (i.e., ChIP-seq, ATAC-seq, Hi-C, DNase-seq, whole-genome 
bisulfite sequencing [WGBS], short and long-read RNA-seq, eCLIP, and labeled proteomic 
mass-spectrometry; Fig. 1D & S1.3a). All our datasets were processed according to both the 
personal diploid and reference genomes, giving rise to three mappings and signal tracks for 
each assay (maternal and paternal haplotypes and the reference; Fig. S1.4). When we applied 
strict mapping criteria (in terms of allowed mismatches) we found ~2.5% more reads mapped to 
the personal genomes than to the reference (Supplement). The increase was smaller in 
annotated regions (genes and cCREs) than in the genome overall. Still, mapping to the personal 
versus reference genome has an effect on gene expression quantification (e.g. resolving better 
the expression levels of immune-related genes; Fig. S1.4). 
 
Measuring AS activity in diverse assays  
(RNA/ChIP/ATAC/DNase)-seq. For the assays making up the bulk of the dataset, AS 
measurement involves the direct comparison of the number of mapped reads at a locus 
containing heterozygous SNVs (hetSNVs), and we report the number of significantly imbalanced 
hetSNVs relative to accessible hetSNVs (i.e., hetSNVs with enough sequencing depth to be 
able to detect statistically significant imbalances; Fig. 2A and Supplement). We performed these 
calculations uniformly on a large scale with a standard pipeline, making possible consistent call-
set comparison, and with reads mapped to personal genomes, avoiding reference and 
ambiguous-mapping biases (Fig. 2 & Supplement) (7, 8, 17, 24-27). We also developed 
alternate call sets, including "high-power" ones based on joint calling across tissues (Fig. 
S2.1e). As shown in Fig. 2D, we consistently detected ~800 AS hetSNVs per sample, about 3% 
of the potential 27.5K accessible hetSNVs.  
WGBS, Hi-C & Proteomics. For three assays we have had to assess AS activity in a specialized 
fashion. In particular, for WGBS, we accounted for base changes at potentially methylated CpG 
sites (Supplement and Fig. S2.2). We identified ~130K AS methylation events per sample. For 
Hi-C, we mapped the reads onto the personal genomes and generated haplotype-resolved 
contact matrices, partitioning the Hi-C contacts, where at least one of the contacting regions 
were AS, into AS interactions (Supplement & Fig. S2.3a). Of the average ~6.5M interactions per 
sample, ~500K showed significant AS behavior (Fig. S2.3). Finally, for proteomics we mapped 
peptides directly to the personal genomes, calling AS peptides in consistent fashion to the 
processing for AS RNA-seq (contrasting to other approaches (28-30)); in total, we found 2,028 
potential AS peptides (Fig. S4.4c and Supplement). 
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Aggregating AS events, forming a catalog 
  
AS Elements. In addition to determining AS activity at the SNV level, it is possible to pool the 
reads from multiple phased SNVs into a single genomic element, allowing the determination of 
AS elements (cCREs and genes, Fig. 2A and Fig. S3.1). In particular, for each individual and 
tissue, 182 cCREs and 351 genes showed a significant AS imbalance per assay; further 
aggregating across individuals resulted in ~400 AS elements per tissue (Fig. 2D). When 
comparing the resulting list with genes associated with specific diseases, we found sensible 
correlations; for example, TSHR, TG, and PAX8, which are associated with hyperthyroidism, 
showed AS behavior in thyroid (more examples in Supplement).  
  
Tissue & Assay Merging. Next, we merged the 25 tissues, using a simple union of the tissue-
specific AS call sets, detecting ~5.5K unique AS hetSNVs (for either binding or expression) and 
~1K AS genomic elements for each individual per assay (Fig. 2C). Pooling the reads from each 
assay across all tissues dramatically increased (by >5X) the detection power, making it possible 
to identify ~27K AS hetSNVs per assay for each individual (Fig. 2D). Finally, merging across all 
assays provided a catalog of all loci where AS activity could be assessed in any of the tissues of 
the four individuals (Fig. 2D). For (RNA/ChIP/ATAC)-seq, the catalog contains 232K unique AS 
hetSNVs and 37K AS elements (28K cCREs and 9K genes, occurring in at least one donor and 
assay). The number of AS hetSNVs increases by ~2-fold (to 0.5M hetSNVs) when aggregating 
across tissues by pooling all the available reads. When AS sites from DNase-seq and 
methylation are added, the total number of hetSNVs increases to 1.3M (many in relation to 
previous efforts, Supplement).  
Mining the catalog   
 
Rare Variants. After constructing the catalog, we mined it for features associated with AS 
activity. First, consistent with previous studies (17, 18, 26, 31), we found that AS elements, 
particularly distal ones, were under less purifying selection (depleted in rare variants) than non-
AS ones (Fig. 3A & S4.2). That said, a substantial number of AS variants are rare (8294 and 
2961 for binding and expression, respectively; Supplement).  Moreover, 14 of these were 
deleterious and pathogenic, based on inter-relating with ClinGen/ClinVar (Supplement) (32).  
 
Model. We built a deep-learning model to predict whether a hetSNV position in an individual is 
AS in a particular assay based solely on the surrounding nucleotide sequence (33). In particular, 
the model was trained as a binary classifier in one individual and was then used to predict on 
non-shared hetSNVs in another (Supplement). As shown in Fig. 3B, the CTCF model has 
stronger performance than the ones for other assays (e.g. RNA-seq) and attaches higher 
importance to the central region surrounding the hetSNV, perhaps because of the well-defined 
CTCF binding motif.   
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Cross-assay Compatibility. We investigated the compatibility of AS activity across different 
assays, on a genomic scale, by assessing whether highly expressed alleles generally have 
more active promoters, indicated by a stronger active chromatin signal and weaker repressed 
one (Fig. 3C). As expected, there was substantial correlation in AS activity between H3K27ac 
and expression, with similar results for the other assays (e.g. expression with ATAC-seq or 
methylation), taking into account the opposing trend for repressive marks and methylation (Fig. 
3D & S4.4a). A similar compatibility relation can also be found between AS activity and GTEx 
eQTLs, giving rise to annotations on the eQTLs (Fig. 3D & S4.4a for expression and binding for 
a given hetSNV, respectively). Fig. 3E summarizes the overall great degree of compatibility, 
with an associated list of strongly compatible gene-promoter pairs (Supplement). Counter to the 
overall trend is the low compatibility between AS mRNA expression and peptide expression, 
possibly reflecting a role of post-transcriptional regulation (34, 35).  
 
Examples of coordinated AS activity across assays 
 
Next, we describe specific examples of the coordination of AS activity, using diploid signal 
tracks.   
 
Imprinted Locus. In most somatic cells, IGF2 and neighboring H19 are imprinted (36). In several 
EN-TEx tissues, we also observed that H19 is expressed only maternally, and IGF2, only 
paternally, due to AS CTCF binding at an imprinting control region (Fig. 4A) (37). Going beyond 
this, haplotype-resolved Hi-C showed that, on the maternal haplotype, a cCRE upstream of H19 
interacts with this gene but not with IGF2. In contrast, on the paternal haplotype, the same 
cCRE interacts with IGF2 only. 
 
Disease-associated Locus. A novel example of coordinated AS activity is found for DNAH11, a 
gene associated with Ciliary dyskinesia (OMIM #611884). We observed AS methylation in the 
promoter regions to be in the opposite direction of AS expression and activity of H3K4me3 and 
H3K27ac, consistent with transcriptional down-regulation. In fact, some of the AS hetSNVs, 
lying in the promoter, have been identified as eQTLs by GTEx (Fig. 4B). 
 
Coordination over X-chromosome. On chromosome X, we observed gene expression, active 
histone marks, POL2R and CTCF binding skewed toward one haplotype, with repressive marks 
skewed to the other one (Fig. 4C & S5.1a-b). There are notable exceptions: genes on 
pseudoautosomal regions (e.g DHRSX) and documented “escaper” genes (e.g. KDM6A (38)). 
In addition, haplotype-specific Hi-C also manifest strong differences in AS interactions on the X-
chromosome at some loci (illustration for XACT, Supplement & Fig. S5.1c). 
Relating SVs to chromatin & expression 
While most AS activity is assessed using hetSNVs, as in examples above, some is associated 
with indels and SVs (Fig. S6.1a). SVs are distributed over the diploid genome unevenly, and on 
a large scale, their association with chromatin can be different for different haplotypes (Fig. 5A). 
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 




At specific loci, SVs can potentially impact chromatin and gene expression in a (potentially) 
causal fashion.  
 
Between Haplotypes. Fig. 5B shows an example of a heterozygous deletion removing an 
activating region (H3K27ac peak on one haplotype) that potentially reduces the expression of 
the nearby gene (ZFAND2A). As this SV overlaps a known SV eQTL (39), the peak removal 
might represent a mechanism for the QTL. Fig. 5C shows a similar example: a heterozygous 
deletion removing an activating region near PSCA. Here the deletion is not a known eQTL but 
has a similar allele frequency to that of nearby eQTL SNVs and thus might represent the causal 
variant associated with them. (Fig. S6.1c lists additional examples of SV-eQTL connections.) 
 
Between Individuals. Figures 5D & 5E show the analogous situation for homozygous deletions 
between two individuals. The first one shows an SV removing an active region and the 
corresponding downregulation of a nearby lncRNA. The second shows an SV removing a likely 
repressive region (H3K9me3 peak) in an intron of PCCB. This SV is adjacent to a number of 
GTEx sQTL (splicing QTL) sites and potentially affects splicing (Fig. S6.1e).  Moreover, long-
read RNA-seq indicates that both individuals have novel splice isoforms near the SV location. It 
is notable that the EN-TEx dataset makes it possible to directly compare SVs, determined by 
long-read DNA sequencing, with their impact on transcript structure, determined by long-read 
RNA-seq. 
TEs & Chromatin. Having demonstrated the potential impact of specific SVs, we next evaluated 
the relationship between SVs and the neighboring chromatin, genome-wide. We assessed 
whether chromatin significantly changes around SVs (Fig. S6.2a). We grouped SVs based on 
their length, genotype, type (insertion or deletion), or TE involvement (whether they involve 
transposable elements). The first three factors showed little or no relationship to chromatin 
changes (Fig. S6.2b). However, in regions of generally open chromatin, the neighborhood of TE 
SVs showed reduced openness compared to that of non-TE SVs (Fig. 5F & S6.2b). This agrees 
with findings that cells repress active chromatin to suppress the activity of TEs (40-42). 
Alternatively, it could also indicate that TEs tend to insert in regions of closed chromatin. 
Decorating the ENCODE Encyclopedia  
Overview. The previous sections detail the functional genomic activity of diploid genomes. In 
this section, we relate this activity to the haploid genome, in the form of "decorations" on the 
cCRE Registry, a major component of the ENCODE Encyclopedia.  
  
In particular, we can decorate cCREs (on the reference genome) in a tissue- and allele-specific 
fashion (15). Moreover, the existing Registry provides only active annotations (10). Given the 
uniform nature of EN-TEx data across tissues and the comprehensive assays, which include 
repressive marks, we can add a fuller description of regulation to the encyclopedia (i.e., active, 
repressed, or bivalent); we can also consistently assess the activity variation of an element 
across tissues and individuals. Finally, our decorated elements can be used to interpret the 
functional variants, such as eQTL and GWAS SNVs. 
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Approach. Starting with a tissue-independent list of regulatory elements (0.9M cCREs in the 
Registry) (10), we used active histone marks, such as H3K27ac, to determine elements active in 
particular EN-TEx tissues (Fig. 6A & S7.2). Moreover, we defined a stringent subset of these 
based on a strong double-peak H3K27ac pattern (Supplement) (43). In addition, using 
repressive histone marks and methylation we could define tissue-specific subsets of Registry 
elements as repressed or bivalent. Note that in order to be included in the encyclopedia 
Registry an element must have been identified as active in at least one ENCODE biosample. 
Thus, even if an element is repressed in all EN-TEx tissues, it is still capable of being active. 
Alternatively, we can identify genomic regions with no active marks in all of ENCODE and only 
repressive ones in EN-TEx (i.e. not in the Registry at all; Fig. S7.3).  
 
Finally, we validated our active and repressive decorations using tissue-matched Hi-C (Fig. 6B). 
Then, most importantly, we used our AS catalog to further decorate elements as AS.   
 
Variation over Individuals, Tissues & Assays. For the decorated cCREs, we quantified their 
differential activity in different tissues of the same individuals, enabling calibrated inter-tissue, 
inter-individual, and inter-assay cross-comparisons. Overall, the decorated cCREs exhibit much 
larger differences in functional genomic activity across tissues than between the same tissues of 
different individuals, using joint analysis of variance (44) (Fig. 6C).  
 
We also developed a regression-based approach to consistently quantify the difference 
(expressed as the fraction of unexplained variance) between any two types of functional 
activities (across cCREs or genes) between individuals, tissues and assays (Supplement & Fig. 
S7.5; all pairwise comparisons available in a matrix). For instance, our approach demonstrated 
that for spleen the H3K27ac variation across cCREs of one individual explained 86% of the 
variation in another. This similarity in explained variation is larger than the degree to which the 
variation across cCREs in spleen could explain the analogous variation in transverse colon in 
the same individual (65%). On average, histone marks between individuals differed by 17% in 
terms of unexplained variation, and between tissues, by 26% (Fig. S7.5b); these numbers were 
larger than the amount of RNA-seq variation unexplained (across genes). We can also compare 
cross-assay, finding, for instance, that H3K27ac in the spleen explains much more of the 
variation in H3K4me3 than H3K4me1. Finally, we can consistently expand these comparisons to 
correlating RNA with protein abundance, finding that it varies considerably between tissues, in 
line with previous studies (Fig. S7.5c) (45). 
Measuring tissue specificity 
The uniform nature of EN-TEx data is ideal for measuring tissue-specificity across the body. We 
used a simple approach, applicable across diverse annotations, coding and non-coding genes, 
cCREs, TSSs, and epigenomic profiles (Fig. 7A & S8.1, Supplement). As expected (46, 47), 
only a small percentage of protein-coding genes had activity in a single tissue (~8%; by RNA-
seq or mass spectrometry); in contrast, pseudogenes and lncRNAs were more tissue-specific. 
Active regulatory elements generally exhibited even higher tissue specificity, while repressive 
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elements tended to be more ubiquitous. As expected, active distal elements were more tissue-
specific than the proximal ones. 
 
AS Elements. AS genes and cCREs were more tissue-specific than corresponding non-AS 
ones, across a wide variety of assays (Fig. 7A & S8.1d). That said, we identified 43 elements 
that are AS across all available tissues (23 cCREs and 20 genes, 14 of which are associated 
with housekeeping genes; Fig. S8.2c,d (48)). For these 43, the direction of AS imbalance was 
consistent across tissues (Fig. 7C-D & S8.2). This fact, and that we did not observe many loci 
where the imbalance direction flipped across tissues, supports our aggregation strategy for 
calling AS events (Fig. 2 & Supplement). 
 
Conservation. Finally, we explored the relationship between tissue specificity and purifying 
selection (Fig. 7B & Supplement). As expected, ubiquitously active elements were under the 
strongest negative selection, and ubiquitously repressed elements were the least evolutionarily 
conserved. Elements that were active or repressed but tissue-specific demonstrated 
intermediate conservation (Fig. S8.3).  
Relating Encyclopedia decorations to QTLs & GWAS loci 
eQTLs/sQTLs. We analyzed the relationship of our decorated regulatory elements with eQTL 
and GWAS SNVs. First, we systematically estimated the enrichment of eQTL and sQTL variants 
in active cCREs from the matched tissue type (Fig. 8A & S9.1a). There was stronger proximal 
than distal enrichment, especially, as expected, for sQTLs (49). Also, the EN-TEx decorated 
cCREs exhibited somewhat stronger enrichments than matched ones from the Roadmap 
project, probably due to their compact size (Fig. S9.1c). Next, we compared eQTL/sQTL 
enrichment in AS elements to non-AS ones (Fig. 8A), finding higher enrichment in AS subsets. 
In particular, for distal active cCREs, the AS ones showed significantly higher enrichment across 
all tissue types. On average, the improvement was >2X for the subset with CTCF bound, with 
some tissues considerably larger. (Note, this subset has more TF-binding sites than other 
cCREs, suggesting greater regulatory importance [Fig. S9.3].) 
 
In addition, we found that the differential histone modifications across EN-TEx tissues can 
potentially be used to predict the tissue specificity of eQTLs; in particular, the presence of an 
H3K27ac signal at a GTEx eQTL SNV is strongly correlated with the tissues the eQTL is active 
in (Fig. 8B & S9.1d). 
  
GWAS. Similar to eQTLs, we demonstrated that AS decorations can produce significantly better 
GWAS enrichment for disease traits (Fig. 8C & S9.2). As a baseline, we estimated the GWAS 
enrichment in tissue-specific regulatory elements across diverse traits (using tag-SNP and 
LDSC approaches (50)). Several of our results recapitulated known biology (Supplement & Fig. 
S9.2b). We then compared the GWAS enrichment patterns in cCREs that were and were not 
AS, finding the AS subset had stronger enrichments. For example, in the coronary artery AS 
elements had higher enrichment for cardiovascular disease compared to non-AS ones (51-54). 
(We also compared this to Roadmap annotations.)  Finally, for specific immune-associated 
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traits, we show AS cCREs achieved the better enrichment tissue specificity for spleen compared 




Many recent efforts have demonstrated that functional annotation of the reference genome 
improves the fine-mapping of disease variants (55-58). The unique advantage of EN-TEx is that 
the genetic variants and their functional annotations are determined for the same individual. 
This matching provides potentially direct insights into the mechanism by which the variants 
influence gene activity. Moreover, EN-TEx demonstrates that diploid functional genomics can be 
brought back to traditional haploid reference genome in a useful form, improving the detection 
and tissue characterization of functional genetic variants.   
 
Resource. A key contribution of EN-TEx is the creation of a broadly useful resource, enabling 
additional analyses outside of the scope of this paper. For example, the methylation data can be 
combined with biological clocks and related to the ages of the EN-TEx individuals (Fig. S10.5). 
In another example, one can see the cross-tissue epigenetics of the genes associated with 
COVID-19 (Fig. S10.6). 
 
All of the EN-TEx data are fully open-consented (Supplement); this consent is invaluable and is 
different from that in many other resources (e.g. GTEx, Roadmap, TCGA, and PsychENCODE) 
and has been shown to greatly improve data set utilization. In particular, all the raw sequencing 
data, annotations and decorations from downstream analyses, and associated tools can be 
freely downloaded (Supplement). These include the diploid and reference signal tracks, TAD 
annotations, a complete catalog of AS events, lists of tissue-specific active and repressive 
regulatory elements (Supplement & Fig. S1.3g). Finally, we developed two interactive 
applications for visualizing the resource (Supplement, Fig. S10.3 & S10.4): The first performs a 
variety of dimensionality reductions on the data (e.g. VAE and UMAP); the second is a 
chromosome “painting” tool for visualizing large-scale diploid maps of functional genomics 
signals.   
  
Selection & Buffering. A central question addressed by the resource is the biological impact of 
genetic variants. As expected, broadly and consistently active elements (e.g. housekeeping 
genes and ubiquitously active promotors) tend to be under strong constraint (i.e. purifying 
selection) and are less likely to be AS (Fig. S9.3a). The buffering hypothesis posits a 
mechanism for this (16): redundancy in important elements may dampen the impact of variants. 
For instance, redundant TF binding sites in cCREs can buffer the loss of a site from a genetic 
variant. However, this buffering is not always perfect: the subset of cCREs that are AS are likely 
not fully buffered, allowing the AS variants to have stronger functional impact. This is consistent 
with our observed enrichment of eQTL SNPs in this subset and provides a rationalization for 
how our AS decorations can refine the regulatory regions responsible for driving expression 
changes. 
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Rare Variants. Taken together, the four EN-TEx individuals have millions of genetic variants. 
Although considered healthy, they are expected to contain many rare, deleterious, or even 
disease-associated mutations, especially recessive ones. These rare variants are not normally 
accessible to traditional QTL studies, which are best powered for common variants. In contrast, 
the matched functional genomics data and AS analysis in EN-TEx can provide information on 
rare variants and in this regard is particularly informative to precision medicine. Moreover, in the 
future, the approach piloted by EN-TEx could be readily scaled up to more individuals, providing 
information on more rare variants -- in contrast to the situation for common variants, where a 
scale-up would provide diminishing amounts of information on new variants.  
 
Overall, ENTEX provides comprehensive tissue-specific maps of molecular phenotypes with 
matched genotypes. These data are valuable for developing and testing models of genotype-
phenotype relationships, which is fundamental to population genetics and precision medicine. 
Moreover, the EN-TEx approach can be readily extended to model organisms (59-68).  
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Fig. 1. Personal genome & data matrix. 
(A) Illustration of the personal genome in contrast to the reference genome. The personal 
diploid genome of individual 3 is shown at the top of the panel. Its construction explicitly 
considers SNVs, indels, and SVs. The chromosomes are phased with long-read sequencing to 
form phased blocks. With known imprinting events (yellow) in the human genome, the maternal 
(blue) or paternal (red) origin of many of the phased haplotype blocks can be identified (see 
Supplement). Taking chromosome 13 (chr13) as an example, it contains two phased blocks, 
one of which has its maternal and paternal haplotypes identified based on an imprinted gene's 
AS expression patterns. A schematic diagram of a genomic region in chr13 shows the detailed 
differences between the personal diploid genome and the reference haploid genome. Because 
of the genetic variants in the personal genome, the diploid representation and the reference 
have different coordinate systems.   
(B) Mapping reads to personal and reference genomes. Due to the genetic variants in the 
diploid personal genome, some reads can be only mapped to this but not to the reference 
genome. Such reads (yellow) are referred to as “personal genome unique”. Compared to the 
reference genome, using the personal genome results in ~2.5% more mapped reads for various 
functional genomic experiments. This fraction ranges from ~1% for RNA-seq to ~4% for Hi-C 
data (more details in the Supplement and Fig. S1.4). 
(C) Classification of SVs detected in individual 3. The SVs are classified according to their type 
(e.g., insertion vs. deletion) and mechanism (e.g. transposable elements or not). 
(D) Data matrix for the EN-TEx resource. Each voxel in the cube stack corresponds to a 
functional genomic assay for a particular tissue from one of the four individuals. A dark grey 
voxel indicates that the functional genomic data have been generated. The total experimental 
counts per assay across the tissues and individuals are shown above the cube stack. The total 
experimental counts per tissue type are shown on the left. The color scheme of the tissues is 
adopted from GTEx (6).  
 
Fig. 2. Measuring AS Activity, Aggregating AS events & Forming a Catalog 
(A) Schematic illustrating the measurement of AS events at heterozygous SNV (hetSNV) loci 
and in genomic elements (e.g., cCREs). The two haplotypes for a genomic region are labeled as 
Hap1 and Hap2. In this region, there are three hetSNVs; thus, the reads overlapping these SNVs 
can be unambiguously mapped to either Hap1 or Hap2. For each hetSNV locus, we can test the 
resulting imbalance between the reads for Hap1 or Hap2. As shown, the hetSNV to the right 
lying outside of the cCRE does not have a significant imbalance (equal number of reads from 
Hap1 and Hap2). In contrast, the two hetSNV loci (to the left) in the cCRE have significant 
imbalances, i.e., 13 reads from Hap1 vs. 1 from Hap2 and 14 vs. 2, and thus are AS. Moreover, 
for the cCRE element as a whole, we can aggregate the reads from these two loci (i.e., 27:3 in 
this example). The imbalance test using this new ratio indicates whether the element as a whole 
is AS (see the Supplement for technical details). A standard pipeline is used for the primary 
assays such as RNA/ChIP/DNase/ATAC-seq, maximizing the consistency of the results; 
moreover, the pipeline is configured to reduce ambiguous read mapping bias (see Supplement 
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and Fig. S1.1) (17, 69). Specialized pipelines are used for methylation, proteomics, and Hi-C 
(see Supplement and Fig. S2.2 & S2.3).   
(B) Frequencies of the AS loci in the personal genome. With panel A procedures, the AS 
hetSNV loci and AS cCREs are identified for the different functional genomic data from each 
tissue of the four individuals (using the GTEx coloring for the tissues and the shapes to indicate 
the different individuals, from Fig. 1). Taking H3K27ac data from the spleen from individual 1 
as an example, there are 2.6k AS hetSNV loci and 0.7k AS cCREs. Most of the assay types have 
similar numbers of AS loci across EN-TEx tissues and individuals, as indicated by the box 
plots.       
(C) Aggregating different tissues for AS detection. Here hetSNVs are indicated in red if they are 
significantly imbalanced (i.e. AS) and gray, if not. One approach to aggregation is to take the 
union of all AS hetSNVs (i.e., significantly imbalanced hetSNVs) from different tissues to 
identify unique AS loci in the genome. The hetSNVs that are AS in any tissue are considered as 
AS, and this rule can also be applied for detecting AS elements. This approach is referred to as 
the “union approach.” Another approach is “pooling” the haplotype-specific reads at an hetSNV 
locus (regardless of its being AS or not in particular tissue) across the tissues to conduct the 
imbalance test. Such reads may not be significantly imbalanced (and thus not AS [gray in the 
figure]) in any given tissue sample, but pooling across many samples may increase the statistical 
power to observe an AS event at the locus (indicated in red). 
(D) Using the two aggregation approaches to construct the AS catalog. (1) As a reference, 
H3K27ac from the spleen in individual 1 is re-shown (from panel B) using the direct 
ascertainment shown in panel A. (2) For H2K27ac, aggregating the spleens from the four 
individuals (union approach in panel C) results in 9.3K AS hetSNVs and 2.5K AS elements. (3) 
For H3K27ac, aggregating the different tissues of the same individual with the union approach 
results in 11K AS hetSNVs. In contrast, using the pooling approach to aggregate the different 
tissues of the same individual leads to 27K AS hetSNVs. (4) For H3K27ac, aggregating different 
tissues within the same individual and the tissues across all four individuals simultaneously with 
the union approach results in 30K AS hetSNVs. Using the pooling approach for tissues and the 
union approach for individuals together increases these numbers to 79K. These four different 
strategies focus on either spleen and/or H3K27ac. The average numbers of AS loci detected for 
other tissues and assays are reported in the panel's right column. For each number in this column, 
the red-green-blue operation icon indicates whether we are doing a union, pooling, or averaging 
over individuals, tissues and assays. Finally, at the bottom of the right column, we aggregate all 
the available assays and tissues from all the individuals to determine a final set of AS hetSNVs, 
either by union or pooling (more detail in the Supplement). Note that the AS loci reported in this 
figure are identified using RNA/ChIP/ATAC-seq.  
 
Fig. 3. Mining the catalog. 
(A) Analysis of purifying selection on AS loci. The horizontal axis measures purifying selection 
in terms of the fraction of rare variants, relative to the total number of variants, in a genomic 
region (see Supplement for details).  
(B) The performance of a model predicting AS events for three assays: CTCF, RNA-seq, and 
POLR2A ChIP-seq. The model is trained on AS SNVs from individual 3 and then tested on non-
overlapping SNVs in other individuals. The left panel shows the accuracy in terms of AUROC 
score. The right panel shows the average attention score of the model for the three assays. The 
score is averaged over 2,000 randomly selected test samples. The attention score reflects the 
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weights that the model attaches to different nucleotide positions in the input sequences. As 
expected, the score peaks around the center at the hetSNV for CTCF. Note how more attention at 
the center is given to CTCF (strongest motif), then ATAC-seq and then RNA-seq (which has no 
focusing motif).      
(C) Determining compatibility between AS expression and AS promoter state. Note how the 
compatible expression direction changes for repressive marks. 
(D) Relating AS expression to the AS H3K27ac modification and eQTL effect. On left, for AS 
genes with promoters accessible to H3K27ac, the fraction of H3K27ac ChIP-seq reads in the 
promoter mapped to Hap1 are plotted against the fraction of Hap1 RNA-seq reads. The exact 
read counts giving rise to these fractions for two genes (LAMTOR1 and RPL4P4) are indicated 
in panel C. For the eQTL effect, the slope (beta coefficient) of the leading eQTL associated with 
an AS gene (6) is correlated with the fraction of RNA-seq reads mapped to the alternative allele 
on that gene (overall Pearson’s correlation coefficient = 0.6, p = 0.01). Note that genetic variants 
with slopes around 0 are unlikely to have statistical significance to be identified as eQTLs. This 
also holds for hetSNVs with read fractions of approximately 0.5. 
(E) Compatibility between AS expression and promoter AS chromatin activity. The 
compatibility is measured by the fraction of genes for which AS expression is compatible with 
promoter AS chromatin state or AS peptide expression (see Supplement and Fig. S4.4a). We 
randomly paired genes with promoters (and peptides) to calculate a z-score (more details in the 
Supplement). Compatibility between AS expression and AS methylation (meCpG), H3K9me3, 
and H3K27me3 is weak, potentially because these marks of repressed chromatin can also be 
associated with genes poised for transcription or genes that are actively transcribed (70, 71). 
 
Fig. 4. Examples of coordinated AS activity across assays. 
(A) AS events detected at a known imprinted locus: H19/IGF2. Functional genomic signals are 
measured in the gastrocnemius medialis of individual 2. In agreement with the known imprinting 
mechanism (top), we detected AS expression of H19 on haplotype 2 (maternally expressed) and 
expression of IGF2 on haplotype 1 (paternally expressed) along with CTCF in the imprinting 
control region of haplotype 2. Consistent with the expression data, we found an AS Hi-C 
interaction between an upstream cCRE and H19 on haplotype 2 (the bold blue arc), and an AS 
interaction between the same cCRE and IGF2 on haplotype 1 (the bold red arc). Other 
neighboring AS Hi-C interactions (which have fewer read counts or connect near but not onto 
the relevant genes) are also depicted with shaded arcs. 
(B) AS events detected at an uncharacterized, disease-associated locus: the DNAH11 gene 
associated with ciliary dyskinesia. The polarity of the AS DNA methylation in the promoter 
region is in the opposite direction to that of the AS expression and chromatin state in the gene 
body, consistent with transcriptional downregulation in cis and the repressive nature of 
regulatory DNA methylation. Also, the active epigenetic marks H3K4me3 and H3K27ac 
demonstrate consistent AS imbalances. Moreover, most of the AS hetSNVs associated with 
DNAH11 are known eQTLs from GTEx. One such hetSNV (rs11760336) lies within the 
DNAH11 promoter, consistent with its effect on gene expression. Also indicated is that some of 
the AS hetSNVs overlap with known GWAS variants.  
(C) Coordinated AS activity across a chromosome. Haplotype 1 of ChrX is inactivated in 
individual 3. The signal tracks show that, in the tibial nerve, Hap1 ChrX generally has lower 
expression levels, lower H3K27ac levels, and higher H3K27me3 levels than Hap2 ChrX. In 
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contrast, the histograms on the left show that the autosomes display balanced gene expression 
and histone modification levels between the two haplotypes. The top inset bar graphs show the 
expression of five example genes. DHRSX, located in the pseudoautosomal region (pink bars at 
the ChrX ends of the signal track), and KDM6A, known to escape ChrX-inactivation, show 
balanced expression between haplotypes. In contrast, TBL1X and SLC25AC fall in the 
inactivated region of ChrX, showing lower Hap1 expression. Expression of XIST is known to 
induce ChrX inactivation and is, therefore, higher in haplotype 1. 
 
Fig. 5. Relating SVs to chromatin & expression. 
(A) The chromosomal distribution of SVs in individual 3 is shown as SV density. The zoom-in 
views add (to the SV density) the average H3K27ac level and expression level of RNA. Two 
examples are shown in panels B and C. 
(B) A 2.6-kb deletion in Hap2 reduces ZFAND2A expression in the thyroid, consistent with 
previous work (39). This deletion removes several H3K27ac peaks from Hap2 (more detail in 
Fig. S6.1b). 
(C) A 98-bp deletion in Hap2 removes an H3K27ac peak downstream of PSCA, potentially 
contributing to the lower gene expression in Hap2. This is in the transverse colon of individual 3. 
The heights of the green bars indicate the allele frequencies of the deletion and the surrounding 
GTEx eQTLs in Hap2. The frequencies are similar, suggesting the SV is potentially in linkage 
disequilibrium with the eQTL variants. (Note, the height of a green bar plus its corresponding 
magenta bar equals 1.) Similar results are observed in two other tissues (see Fig. S6.1c).  
(D) A 2.3-kb homozygous deletion in individual 3. This SV removes an H3K27ac peak 
downstream of lncRNA RP11-362F19.1, which has lower expression in this individual. The 
nearby CTCF peaks suggest a potential interaction between the H3K27ac peaks downstream 
and upstream of the lncRNA and may indicate a mechanism by which the loss of the H3K27ac 
peak reduces the gene expression. See Fig. S6.1d for more detail. 
(E) A 5.2-kb homozygous deletion in individual 2. This SV removes an H3K9me3 peak, 
potentially increasing PCCB expression in individual 2. The sashimi plots show examples of 
novel splicing isoforms identified by long-read RNA-seq, which may be associated with the SV. 
Fig. S6.1e shows more detail on the splicing isoforms. The differences in splicing between 
individuals 2 and 3 could reflect the SV disrupting regions important to splicing, as suggested by 
the known GTEx sQTL sites nearby (72). Alternatively, the differences in splicing between the 
two samples may be caused by tissue specificity: the individual 2 sample is from the adrenal 
gland, and the individual 3 sample is from the heart left ventricle. See Fig. S6.1f for another 
example of novel splicing variants that are potentially associated with an SV.    
(F) The genomic regions neighboring TE SVs show reduced chromatin accessibility. The 
change in accessibility is determined by comparing the accessibility (from ATAC-seq) of 
individuals 2 and 3, taking as a reference the one without the SV (see Supplement & Fig. 
S6.2a). The x-axis is the chromatin openness in the reference individual. P-values are based on 
the Chi-squared test. 
 
Fig. 6. Decorating the ENCODE Encyclopedia. 
(A) Workflow for decorating cCREs by personal functional genomic data. The workflow starts 
with the master list of cCREs from the ENCODE Registry. These 0.9 million cCREs are not 
necessarily tissue-specific. The spleen is used as an example to illustrate the tissue-specific 
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decoration of these cCREs. In this tissue, 290k cCREs have functional genomic signals and can 
be categorized as active (117k), repressed (154k), or bivalent (19k). Then for each category, the 
cCREs can be consecutively classified according to their genomic locations (proximal or distal), 
CTCF binding, and allele specificity. (This classification can occur in any order.) As a result, the 
spleen has 2,866 AS cCREs with various genomic activities and locations. More details on the 
workflow are described in the Supplement. The numbers of active and repressed cCREs are 
comparable in each tissue (i.e., on average ~202k active and ~166k repressed cCREs).  Only a 
small subset of the active cCREs exhibit AS activity (~2.5% or 1,750 cCREs, averaging across 
tissues; see Fig. S7.2d for all available tissues).    
(B) The relationship between decorated cCREs and chromatin compartments from Hi-C. Active 
and tissue-specific cCREs are more likely to be located in the active compartment (A), while 
repressed tissue-specific cCREs are relatively skewed to compartment B (see Fig. S7.4 for all 
available tissues). 
(C) Functional genomic data across individuals, tissues and assays. The joint analysis of 
variation  is used to aggregate the functional data (JIVE) (44) into two-dimensional projections 
(showing each individual-tissue pair as a dot) for each assay and then into a single overall 
combined projection for all assays. (The tissues are colored according the GTEx convention 
from Fig. 1 and for each tissue the number of colored dots indicates the number of individuals, 
up to four.) In addition, a linear-regression-based approach is used to measure the difference 
between functional genomic signals in different tissues, assays, or individuals (details in 
Supplement). The difference is measured by one minus the explained variance of the 
regression. For example, on average, for H2K27ac 14% of the variation across the cCREs 
between the spleens of two individuals was unexplained (resulting in a dissimilarity between 
individuals). The corresponding dissimilarity was also small (15%) between the transverse 
colons of two individuals. In contrast, the average dissimilarity between these two types of 
tissue (in the same individual) increases to 35%. For H3K27me3, the dissimilarity between 
different tissues is also high (42%). The dissimilarities between different types of functional 
activity are even higher: in particular, the dissimilarity between H3K27ac and H3K4me3 is 51%. 
A similar analysis can also be done comparing RNA and protein abundances. A large-scale 
analysis for all available assays and tissues indicates that the dissimilarity is markedly assay 
and tissue-specific (see Supplement and Fig. S7.5). 
 
Fig. 7. Measuring tissue specificity. 
(A) Tissue specificity of various genomic annotations. For a given element, tissue specificity is 
measured by the number of tissues for which the element is active (see Supplement and Fig. 
S8.1 for more detail). Then by determining the fraction of elements in an annotation category 
(e.g. distal active cCREs) that are active in just one tissue, we determine fractional uniqueness 
for that category. A smaller uniqueness indicates a category that is more ubiquitous. The plot 
shows uniqueness values for many diverse annotation categories.  
(B) Purifying selection on active and repressed cCREs in relation to tissue specificity. Purifying 
selection is measured as the fraction of rare variants to the total number of variants in an 
element (details in the Supplement). Rare variants are determined from 1,000 Genomes. A 
subset of active cCREs with a strong "peak-valley-peak" pattern of H3K27ac signal is identified 
("stringent subset", see Supplement), and this set of cCREs has increased purifying selection. 
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(C) The direction of AS imbalance across accessible cCREs. The imbalance between the two 
haplotypes is measured by the fraction of AS reads that map to haplotype 1. A zoomed-in view 
of the most ubiquitous (non tissue-specific) AS cCREs shows that the imbalance direction is 
consistent across tissues. However, a few tissue-specific cCREs show directional flips between 
tissues. 
(D) Distribution of cCREs with AS H3K27ac in tissues of individual 3 is shown in an UpSet plot. 
Most of these AS cCREs are detected only in a single tissue but are not AS in other tissues. 
However, a few AS cCREs are observed across many tissues. 
 
Fig. 8. Relating Encyclopedia decorations to QTLs & GWAS loci. 
(A) Comparing the effect of AS decoration for eQTL (top left) and sQTL (bottom left) enrichment. 
Colored dots show the enrichment for each tissue (using the GTEx colors from Fig. 1). Each bar 
shows the median enrichment over all tissues for a given decorated annotation subset. Overall, 
AS elements show stronger enrichments compared to non-AS ones. Median enrichment of 
Roadmap “Enh” and “TssA” annotations are shown as dashed and dotted lines, respectively, as 
a reference. The enrichments for the liver are highlighted. To estimate the robustness of this 
particular calculation, we resampled the genetic variants as described in Fig S9.1, estimating a 
range of enrichments, shown with whiskers. (Also, see Fig. S9.1a for enrichment results on all 
tissues and the Supplement for more detail.) 
 
(B) The relationship between the tissue-specificity of GTEx eQTLs and H3K27ac signal. For 
each eQTL SNV we observe H3K27ac signal present in most tissues where the eQTL is active 
(right-hand-side) and absent in the tissues where the eQTL is not active (left-hand-side). Thus 
H3K27ac signal in different tissues can be used as a predictor of tissue activity for each eQTL 
SNV (see also Fig. S9.1d). 
(C) GWAS tag SNP and LDSC enrichment of EN-TEx AS decorations. The heatmap (center) 
shows the GWAS tag SNP enrichment of distal active CTCF+ cCREs. The tissues (colored 
according to the GTEx convention from Fig. 1) run along the bottom, and phenotypes (usually 
diseases, not explicitly labeled) run along the vertical axis. Around the heatmap, we show 
zoomed-in views highlighting various comparisons. At the bottom, we show that the tissue 
specificity of the enrichment for the trait Granulocyte % of Myeloid WBC is much stronger for AS 
versus non-AS cCREs. On the left, we show higher LDSC enrichment for AS elements 
compared to the corresponding non-AS ones for one tissue (coronary artery) across many 
associated traits. Left-bottom extends this comparison (for a single tissue-trait pair) to include 
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